KRAS and colorectal carcinoma: Although hyperlipidemia, antioxidants, and inhibition of KRAS have the possibility to impact tumor metastasis through vascular modification, such as tubular formation and permeability, we conclude that hyperlipidemia can directly confer the metastatic ability to CRC cells and can be inhibited by antioxidants and statin.